Rights and permissions
About this article
Cite this article
Gemfibrozil warranted for primary prevention of CHD. Pharmacoecon. Outcomes News 473, 5 (2005). https://doi.org/10.2165/00151234-200504730-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504730-00011